| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Entrada Therapeutics, Inc. (TRDA) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 22 sells. TRDA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.68M | $32.56M | - | |
| 10% | 2.85M | $19.81M | -116,474 | |
| 10% | 2.85M | $19.81M | -116,474 | |
| CEO | 526.0K | $3.66M | - | |
| Pres | 216.3K | $1.51M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 6, 2023 | Wentworth Kory James61 | Chief Financial Officer | Sell | 950 | $13.48 | $12,806.17 | -0.9% | +1.2% | +10.9% | |
| Sep 6, 2023 | Kreher Nerissa54 | Chief Medical Officer | Sell | 892 | $13.48 | $12,021.75 | -1.1% | +1.2% | +10.9% | |
| Sep 6, 2023 | Dowden Nathan J70 | Chief Operating Officer | Sell | 972 | $13.47 | $13,089.09 | -1.0% | +1.2% | +10.9% | |
| Aug 14, 2023 | Doshi Dipal62 | President And CEO | Sell | 1,000 | $15.67 | $15,671.30 | -0.5% | +6.7% | +2.9% | |
| Aug 4, 2023 | Kreher Nerissa54 | Chief Medical Officer | Sale+OE | 26,710 | $14.76 | $394,219.20 | -16.3% | +10.0% | +3.5% | |
| Jul 11, 2023 | Dowden Nathan J70 | Chief Operating Officer | Sell | 7,097 | $18.03 | $127,938.18 | -8.7% | -20.9% | -12.6% | |
| Jul 11, 2023 | Sethuraman Natarajan83 | Chief Scientific Officer | Sell | 17,878 | $18.03 | $322,389.28 | -5.3% | -20.9% | -12.6% | |
| Jul 11, 2023 | Wentworth Kory James61 | Chief Financial Officer | Sale+OE | 10,000 | $17.99 | $179,862.18 | -12.0% | -20.9% | -12.6% | |
| Jun 22, 2023 | Dowden Nathan J70 | Chief Operating Officer | Sell | 15,982 | $15.42 | $246,403.31 | -14.8% | -11.2% | -7.1% | |
| Jun 21, 2023 | Wentworth Kory James61 | Chief Financial Officer | Sale+OE | 17,500 | $15.01 | $262,648.25 | -21.3% | -5.1% | -4.7% |